An Open-Label, Sequential, Dose Escalation Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2015
Price : $35 *
At a glance
- Drugs MDT 15 (Primary)
- Indications Radiculopathy; Sciatica
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Medtronic
- 11 Sep 2015 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016 as reported by clinicalTrials.gov.
- 11 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by clinicalTrials.gov.
- 10 Aug 2015 Planned End Date changed from 1 Jan 2016 to 1 Aug 2016 as reported by clinicalTrials.gov record.